Medical Care

Global RDC (Radionuclide Drug Conjugate) Services Market Research Report 2026

This report delivers a comprehensive overview of the global RDC (Radionuclide Drug Conjugate) Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding RDC (Radionuclide Drug Conjugate) Services. The RDC (Radionuclide Drug Conjugate) Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global RDC (Radionuclide Drug Conjugate) Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist RDC (Radionuclide Drug Conjugate) Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Rdcthera
Abzena
WuXi XDC
CD Formulation
CPC Scientific Inc
Segment by Type
Antibody Radionuclide Conjugates (ARC)
Peptide Radionuclide Conjugates (PRC)
Small Molecular Radionuclide Conjugates (SMRC)
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for RDC (Radionuclide Drug Conjugate) Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antibody Radionuclide Conjugates (ARC)
1.2.3 Peptide Radionuclide Conjugates (PRC)
1.2.4 Small Molecular Radionuclide Conjugates (SMRC)
1.3 Market by Application
1.3.1 Global RDC (Radionuclide Drug Conjugate) Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Perspective (2021–2032)
2.2 Global RDC (Radionuclide Drug Conjugate) Services Growth Trends by Region
2.2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Region (2021–2026)
2.2.3 RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (2027–2032)
2.3 RDC (Radionuclide Drug Conjugate) Services Market Dynamics
2.3.1 RDC (Radionuclide Drug Conjugate) Services Industry Trends
2.3.2 RDC (Radionuclide Drug Conjugate) Services Market Drivers
2.3.3 RDC (Radionuclide Drug Conjugate) Services Market Challenges
2.3.4 RDC (Radionuclide Drug Conjugate) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RDC (Radionuclide Drug Conjugate) Services Players by Revenue
3.1.1 Global Top RDC (Radionuclide Drug Conjugate) Services Players by Revenue (2021–2026)
3.1.2 Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Players (2021–2026)
3.2 Global Top RDC (Radionuclide Drug Conjugate) Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by RDC (Radionuclide Drug Conjugate) Services Revenue
3.4 Global RDC (Radionuclide Drug Conjugate) Services Market Concentration Ratio
3.4.1 Global RDC (Radionuclide Drug Conjugate) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RDC (Radionuclide Drug Conjugate) Services Revenue in 2025
3.5 Global Key Players of RDC (Radionuclide Drug Conjugate) Services Head Offices and Areas Served
3.6 Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Products and Applications
3.7 Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 RDC (Radionuclide Drug Conjugate) Services Breakdown Data by Type
4.1 Global RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Type (2021–2026)
4.2 Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (2027–2032)
5 RDC (Radionuclide Drug Conjugate) Services Breakdown Data by Application
5.1 Global RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Application (2021–2026)
5.2 Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)
6.2 North America RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)
6.4 North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)
7.2 Europe RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)
7.4 Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)
8.2 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2021–2026)
8.4 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)
9.2 Latin America RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)
9.4 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)
10.2 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)
10.4 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Rdcthera
11.1.1 Rdcthera Company Details
11.1.2 Rdcthera Business Overview
11.1.3 Rdcthera RDC (Radionuclide Drug Conjugate) Services Introduction
11.1.4 Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
11.1.5 Rdcthera Recent Development
11.2 Abzena
11.2.1 Abzena Company Details
11.2.2 Abzena Business Overview
11.2.3 Abzena RDC (Radionuclide Drug Conjugate) Services Introduction
11.2.4 Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
11.2.5 Abzena Recent Development
11.3 WuXi XDC
11.3.1 WuXi XDC Company Details
11.3.2 WuXi XDC Business Overview
11.3.3 WuXi XDC RDC (Radionuclide Drug Conjugate) Services Introduction
11.3.4 WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
11.3.5 WuXi XDC Recent Development
11.4 CD Formulation
11.4.1 CD Formulation Company Details
11.4.2 CD Formulation Business Overview
11.4.3 CD Formulation RDC (Radionuclide Drug Conjugate) Services Introduction
11.4.4 CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
11.4.5 CD Formulation Recent Development
11.5 CPC Scientific Inc
11.5.1 CPC Scientific Inc Company Details
11.5.2 CPC Scientific Inc Business Overview
11.5.3 CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Introduction
11.5.4 CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
11.5.5 CPC Scientific Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Antibody Radionuclide Conjugates (ARC)
Table 3. Key Players of Peptide Radionuclide Conjugates (PRC)
Table 4. Key Players of Small Molecular Radionuclide Conjugates (SMRC)
Table 5. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million), 2021–2026
Table 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2021–2026)
Table 9. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2027–2032)
Table 11. RDC (Radionuclide Drug Conjugate) Services Market Trends
Table 12. RDC (Radionuclide Drug Conjugate) Services Market Drivers
Table 13. RDC (Radionuclide Drug Conjugate) Services Market Challenges
Table 14. RDC (Radionuclide Drug Conjugate) Services Market Restraints
Table 15. Global RDC (Radionuclide Drug Conjugate) Services Revenue by Players (US$ Million), 2021–2026
Table 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players (2021–2026)
Table 17. Global Top RDC (Radionuclide Drug Conjugate) Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on RDC (Radionuclide Drug Conjugate) Services Revenue, 2025
Table 18. Ranking of Global Top RDC (Radionuclide Drug Conjugate) Services Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Headquarters and Area Served
Table 21. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Products and Applications
Table 22. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Type (US$ Million), 2021–2026
Table 25. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2021–2026)
Table 26. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2027–2032)
Table 28. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (US$ Million), 2021–2026
Table 29. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2021–2026)
Table 30. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2027–2032)
Table 32. North America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026
Table 34. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032
Table 35. Europe RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026
Table 37. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032
Table 47. Rdcthera Company Details
Table 48. Rdcthera Business Overview
Table 49. Rdcthera RDC (Radionuclide Drug Conjugate) Services Product
Table 50. Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026
Table 51. Rdcthera Recent Development
Table 52. Abzena Company Details
Table 53. Abzena Business Overview
Table 54. Abzena RDC (Radionuclide Drug Conjugate) Services Product
Table 55. Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026
Table 56. Abzena Recent Development
Table 57. WuXi XDC Company Details
Table 58. WuXi XDC Business Overview
Table 59. WuXi XDC RDC (Radionuclide Drug Conjugate) Services Product
Table 60. WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026
Table 61. WuXi XDC Recent Development
Table 62. CD Formulation Company Details
Table 63. CD Formulation Business Overview
Table 64. CD Formulation RDC (Radionuclide Drug Conjugate) Services Product
Table 65. CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026
Table 66. CD Formulation Recent Development
Table 67. CPC Scientific Inc Company Details
Table 68. CPC Scientific Inc Business Overview
Table 69. CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Product
Table 70. CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026
Table 71. CPC Scientific Inc Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report


List of Figures
Figure 1. RDC (Radionuclide Drug Conjugate) Services Picture
Figure 2. Global RDC (Radionuclide Drug Conjugate) Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Type: 2025 vs 2032
Figure 4. Antibody Radionuclide Conjugates (ARC) Features
Figure 5. Peptide Radionuclide Conjugates (PRC) Features
Figure 6. Small Molecular Radionuclide Conjugates (SMRC) Features
Figure 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (US$ Million), 2021–2032
Figure 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Application: 2025 vs 2032
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Medical Device Companies Case Studies
Figure 11. Other Case Studies
Figure 12. RDC (Radionuclide Drug Conjugate) Services Report Years Considered
Figure 13. Global RDC (Radionuclide Drug Conjugate) Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global RDC (Radionuclide Drug Conjugate) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region: 2025 vs 2032
Figure 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players in 2025
Figure 17. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue in 2025
Figure 19. North America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)
Figure 21. United States RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)
Figure 25. Germany RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2021–2032)
Figure 33. China RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)
Figure 41. Mexico RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)
Figure 45. Israel RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Rdcthera Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
Figure 49. Abzena Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
Figure 50. WuXi XDC Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
Figure 51. CD Formulation Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
Figure 52. CPC Scientific Inc Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies